TCHOO8

Brief Summary:

This is a 16 week trial to evaluate the efficacy of Nerivio device as a preventive treatment for migraines. This device is currently FDA approved for acute migraine treatment.

View The Flyer For This Study

Additional Flyer For This Study

View More Information On This Study

 

 

INTERESTED IN THIS STUDY?  CLICK HERE TO CONTACT US.